http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H06247858-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3d8536b54b1b1b07d7d3492b68960c3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 1993-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22017748f1aea6838c85f97ea7f4095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5430bdf926e95770a64eb2758a3f4927
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_477942c03e61bcd571da2d381edf802b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36b7c2485153d56b06a41241f707c6de
publicationDate 1994-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H06247858-A
titleOfInvention Anti-osteodystrophy drug in chronic renal failure
abstract (57) [Summary] (Modified) [Structure] A soft capsule containing a liquid formulation consisting of secalciferol (a kind of vitamin D, chemical name = 24R, 25-dihydroxycholecalciferol) and an oil base. The oily base is triglyceride, a medium-chain linear fatty acid that is a mixture of caprylic acid and capric acid. The stabilizer may further contain tocopherol, butylhydroxyanisole, or butylhydroxytoluene. [Effects] Cecalciferol is a preparation which is effective alone against osteodystrophy in chronic renal dialysis patients, has no or extremely few side effects, and is stable enough to be used practically.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840938-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006502193-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4718836-B2
priorityDate 1993-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12895034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11954184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15570435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13783521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395065
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22450148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10149043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226442219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11819645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283748
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226441774

Total number of triples: 49.